Examining the safety, efficacy, and patient acceptability of inhaled loxapine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults

Examining the safety, efficacy, and patient acceptability of inhaled loxapine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults

Justin Faden,1 Leslie Citrome21Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19125, USA; 2Psychiatry & Behavioral Sciences, New York Medical College, Valhalla, NY 10595, USAAbstract: Agitation is a common and serious symptom of bipolar mania and schizophrenia, and can be...

Full description

Bibliographic Details
Main Authors: Faden J, Citrome L
Format: Article
Language:English
Published: Dove Medical Press 2019-08-01
Series:Neuropsychiatric Disease and Treatment
Subjects:
Inhaled loxapine
agitation
schizophrenia
bipolar disorder
mania
antipsychotic
Online Access:https://www.dovepress.com/examining-the-safety-efficacy-and-patient-acceptability-of-inhaled-lox-peer-reviewed-article-NDT

Internet

https://www.dovepress.com/examining-the-safety-efficacy-and-patient-acceptability-of-inhaled-lox-peer-reviewed-article-NDT

Similar Items